SCHEMBL10128192

SCHEMBL10128192

Cc1ccc(-c2cn3c(-c4ccc(-c5cccc6c5oc5ccccc56)cc4)nnc3c3ccccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.43
RXFP1 Q9HBX9 2/20 0.41
MAPT P10636 2/20 0.40
TP53 P04637 2/20 0.40
POLB P06746 1/20 0.40
THRB P10828 1/20 0.39
GGPS1 O95749 1/20 0.36
PRKDC P78527 3/20 0.36
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
MAOB P27338 2/20 0.34
TNKS O95271 1/20 0.34
PARP1 P09874 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
PARP2 Q9UGN5 1/20 0.34
PIK3CD O00329 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10128155 0.93 ALOX5 (0.45) ALOX5RXFP1MAPTTP53POLB
SCHEMBL10128170 0.92 ALOX5 (0.44) ALOX5RXFP1MAPTTP53THRB
SCHEMBL10128131 0.91 ALOX5 (0.45) ALOX5RXFP1MAPTTP53POLB
SCHEMBL10128177 0.90 ALOX5 (0.43) ALOX5MAPTGGPS1PRKDCPIK3CD
SCHEMBL10128185 0.89 ALOX5 (0.40) ALOX5RXFP1MAPTTP53POLB
SCHEMBL10128166 0.89 ALOX5 (0.43) ALOX5RXFP1MAPTTHRBGGPS1
SCHEMBL10128190 0.88 ALOX5 (0.42) ALOX5RXFP1MAPTTP53POLB
SCHEMBL10128167 0.88 ALOX5 (0.46) ALOX5RXFP1MAPTTHRBGGPS1
SCHEMBL10128159 0.88 ALOX5 (0.43) ALOX5MAPTGGPS1PRKDCPIK3CD
SCHEMBL10128164 0.87 ALOX5 (0.46) ALOX5GGPS1PRKDCPIK3CDPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
WO-2012017842-A1 TRIAZOLE DERIVATIVE, HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-02-09 WO disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device HTR3D, KCNQ4, KCNQ3 ALOX5 1457/4885RXFP1 3981/4885MAPT 1271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.